Table III.
Comparison of VAS scores of non-small cell lung cancer patients in the CGEA and TIVA groups at 24, 48 and 72 h after surgery.
| VAS score | |||||
|---|---|---|---|---|---|
| Time, h | Group | 0 point, n (%) | 1–3 points, n (%) | 4–6 points, n (%) | 7–10 points, n (%) |
| 24 | TIVA | 0 (0) | 26 (43.33)a | 16 (26.67) | 18 (30.00)a |
| CGEA | 0 (0) | 47 (78.33) | 13 (21.67) | 0 (0) | |
| 48 | TIVA | 0 (0) | 38 (63.33)a | 17 (28.33) | 5 (8.33) |
| CGEA | 3 (5.00) | 48 (80.00) | 9 (15.00) | 0 (0) | |
| 72 | TIVA | 2 (3.33) | 47 (78.33) | 10 (16.67)a | 1 (1.67) |
| CGEA | 8 (13.33) | 50 (83.33) | 2 (3.33) | 0 (0) | |
a
P<0.05 vs. the CGEA group. TIVA, total intravenous anesthesia; CGEA, combined general-epidural anesthesia.